Sareum - Specialists in Cancer Drug Discovery
Print the page Smaller text Larger text


Holding(s) In Company
09 September, 2014

Holding(s) In Company
11 July, 2014

Japanese Patent Grant
02 July, 2014

Total Voting Rights
30 June, 2014

Preclinical Proof of Concept in TYK2 Programme
26 June, 2014

RSS news feed News feed
requires RSS news reader

Sareum Holdings
Last Trading 0.47
Trade Time 16:07am
Change 0.00
Open 0.47
Day's Range 0.43 - 0.465
Volume 5744396


Sareum's small molecule drug discovery expertise is building value by developing drug candidates, focused on cancer and autoimmune disease, for licencing to pharmaceutical and biotechnology companies


Providing protein structure-based research services to accelerate customers’ drug discovery programmes
Developing oncology drug candidates for licensing to pharmaceutical companies


Learn more about Sareum’s pipeline of targeted small molecule drug candidates

                                                                                            Website last updated on: 16-July-2014



Requires RSS news reader

Requires MS Word

Requires Adobe Acrobat Reader

site map

cookie policy

email: info (at) tel: +44 (0) 1223 497700 fax: +44 (0) 1223 497701